Last $76.61 USD
Change Today +0.28 / 0.37%
Volume 1.5M
DHR On Other Exchanges
Symbol
Exchange
New York
Mexico
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

danaher corp (DHR) Snapshot

Open
$76.59
Previous Close
$76.33
Day High
$76.65
Day Low
$76.02
52 Week High
06/9/14 - $81.14
52 Week Low
09/3/13 - $65.61
Market Cap
53.7B
Average Volume 10 Days
1.8M
EPS TTM
$3.47
Shares Outstanding
700.7M
EX-Date
06/25/14
P/E TM
22.1x
Dividend
$0.40
Dividend Yield
0.33%
Current Stock Chart for DANAHER CORP (DHR)

danaher corp (DHR) Details

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company’s Test & Measurement segment provides test, measurement, and monitoring products that are used in electronic design, manufacturing, and technology development; network monitoring, management, and optimization tools; and security solutions for communications and enterprise networks. Its Environmental segment offers instrumentation and disinfection systems to analyze and manage the quality of water; and solutions and services focused on fuel dispensing, remote fuel management, point-of-sale systems, payment systems, environmental compliance, vehicle tracking, and fleet management. The company’s Life Sciences & Diagnostics segment provides various research and clinical tools for scientists to study cells and its components; and a range of analytical instruments, reagents, consumables, software, and services for hospitals, physician’s offices, reference laboratories, and various critical care settings. Its Dental segment provides dental consumables, equipment, and services for the diagnosis, treatment, and prevention of disease and ailments of the teeth, gums, and supporting bone. Danaher Corporation’s Industrial Technologies segment offers equipment, consumables, and software for consumer and industrial products; and electromechanical motion control solutions for the industrial automation and packaging markets. This segment also provides sensors and controls products instruments to manufacturing markets and electric utility industry; energetic material systems to systems integrators and prime contractors; and supplemental braking systems for commercial vehicles. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, District of Columbia.

danaher corp (DHR) Top Compensated Officers

Chief Executive Officer, President, Director,...
Total Annual Compensation: $1.2M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $745.0K
Executive Vice President
Total Annual Compensation: $635.0K
Executive Vice President
Total Annual Compensation: $630.0K
Executive Vice President
Total Annual Compensation: $625.0K
Compensation as of Fiscal Year 2013.

danaher corp (DHR) Key Developments

Nobel Biocare Said To Draw Interests

Nobel Biocare Holding AG (SWX:NOBN) ) that’s exploring a sale, has attracted interest from potential buyers including EQT Partners AB and Danaher Corp. (NYSE:DHR), said people with knowledge of the matter. Nobel Biocare was initially approached by EQT with an offer of about CHF 17 a share, which would have valued the company at about CHF 2.1 billion said the people, who asked not to be identified because talks are private. The offer prompted Nobel Biocare and its adviser Goldman Sachs Group Inc. (GS) to invite other bids as it seeks a higher price, the people said. Other companies such as DENTSPLY International Inc. (NasdaqGS:XRAY) and buyout firms are also expected to look at Nobel Biocare, the people said. Potential buyers include Straumann Holding AG (SWX:STMN), Sirona Dental Systems Inc., Johnson & Johnson (NYSE:JNJ), Medtronic, Inc. (NYSE:MDT), Zimmer Holdings, Inc. (NYSE:ZMH), Henry Schein, Inc. (NasdaqGS:HSIC), and 3M Company (NYSE:MMM), according to a note on July 30 from Lisa Bedell Clive, a London-based analyst at Sanford C. Bernstein & Co. Nobel Biocare could sell for as much as CHF 18 a share, she said in the note.

Danaher Corp. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 27, 2014; Provides Earnings Guidance for the Third Quarter Ending September 26, 2014; Revises Earnings Guidance for the Full Year of 2014

Danaher Corp. announced unaudited consolidated earnings results for the second quarter and six months ended June 27, 2014. For the quarter, the company reported sales of $4,963.6 million against $4,737.5 million a year ago. Operating profit was $889.3 million against $843.6 million a year ago. Earnings before income taxes were $879.0 million against $805.8 million a year ago. Net earnings were $676.4 million against $616.8 million a year ago. Diluted earnings per share were $0.95 against $0.87 a year ago. Operating cash flow was $1 billion and free cash was $844 million. For the six months, the company reported sales of $9,626.3 million against $9,182.2 million a year ago. Operating profit was $1,678.2 million against $1,574.5 million a year ago. Earnings before income taxes were $1,640.3 million against $1,728.2 million a year ago. Net earnings were $1,256.1 million against $1,308.7 million a year ago. Diluted earnings per share were $1.76 against $1.85 a year ago. The company anticipates that GAAP diluted net earnings per share for the quarter ending September 26, 2014 will be in the range of $0.86 to $0.89. The company also narrowed its diluted net earnings per share guidance for the full year 2014 to $3.67 to $3.72 on a GAAP basis compared to previous range of $3.60 to $3.75.

Danaher Seeks Acquisitions

Danaher Corp. (NYSE:DHR) is seeking acquisitions. Dan Comas, Executive Vice President and Chief Financial Officer of Danaher, said, "Part of the reason we're taking down the high end of our guidance is, we are going to have a fair amount of acquisition noise, a lot of it's non-cash as a result of these five larger deals over the last three months."

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DHR:US $76.61 USD +0.28

DHR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DHR.
View Industry Companies
 

Industry Analysis

DHR

Industry Average

Valuation DHR Industry Range
No financial data is available for DHR.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DANAHER CORP, please visit www.danaher.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.